Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

US Patent 10766881 · Granted Sep 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1,4-dihydroquinazolinone compounds and uses thereof2025
Quinolinone amide compounds and uses thereof2025
Pyridazinone compounds and uses thereof2025
Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Compounds for the treatment of BRAF-associated diseases and disorders2025
Compounds for the treatment of BRAF-associated diseases and disorders2025
Method for increasing number of proteins identified by mass spectrometry2025
Pyridazinone compounds and uses thereof2025
Pyridazinone compounds and uses thereof2025
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases2025